Testing two drugs for long COVID symptoms
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests if combining maraviroc and atorvastatin can help people with long COVID. You must have specific, persistent symptoms like brain fog, severe fatigue, or shortness of breath that started or got worse after a confirmed COVID-19 infection and have lasted over 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You had a positive COVID-19 test and a doctor has diagnosed you with long COVID
- You have had new or worsening symptoms like brain fog, severe fatigue, or shortness of breath for more than 6 months
- You have not taken any statin medication (like atorvastatin) in the last 6 months
- You do not have other conditions that could explain your symptoms, such as Lyme disease, autoimmune disorders, or chronic fatigue lasting 5+ years
- You are willing to use effective birth control if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
This study tests if the drug Anktiva can help people with long COVID. To join, you must have had at least one confirmed COVID-19 infection and now have lasting symptoms that started or got worse after that infection.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.